Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating XXXX .

@entity1 @entity43 @entity632 @entity0 @entity5 @entity1138 @entity900 @entity189 @entity14 @entity413 @entity356
AIM: To report the use of laparoscopic Intraperitoneal Hyperthermic Chemotherapy (LIPHC) in the treatment of @entity5 . METHODS: From September 2001 to December 2003, 14 @entity1 between the age of 56 and 78years were treated. Ascites was from @entity356 (5 cases), @entity14 (3 cases), @entity43 (3 cases), @entity0 (2 cases) and peritoneal mesothelioma (1 case). The LIPHC was carried out at 42 degrees C for 90 min with 1.5% @entity413 solution as a carrier. Chemotherapy was @entity900 and @entity632 or @entity1138 depending on the type of @entity5 . The drains were left in situ after surgery and removed when perfuse drainage ceased. RESULTS: Ascites was controlled in all the treated cases. A CT scan performed in follow-up showed a small, clinically undetectable, fluid accumulation in the pelvis of one @entity1 . CONCLUSIONS: This method resulted in benefit for those peritoneal @entity189 @entity1 with debilitating @entity5 who were excluded from cytoreductive surgery. Proficiency in laparoscopic staging procedures and experience in the management of @entity189 and intraperitoneal hyperthermic chemotherapy (IPHC) are required for the success of the procedure.
